Innovation is accelerating across the pharmaceutical landscape. In this latest issue, we examine advances in AI, cell and gene therapies, continuous manufacturing, PAT, HPAPIs and sustainable solutions, alongside exclusive interviews with industry leaders, a panel discussion on ESG and strategic partnerships in the pharma supply chain, and insights into the evolving challenges of global pharmaceutical development and manufacturing.